Mestag Therapeutics
Omar Salem, PhD, currently serves as a Corporate Development and Strategy MBA Associate at Mestag Therapeutics, focusing on strategic initiatives through market research and competitive analysis. Concurrently, Omar functions as a Global Knowledge Expert in Cellular and Molecular Biology at Enquire AI, facilitating connections between enterprises and experts. Previous experience includes a role as a Research Scientist in Translational Biology at invoX Pharma, where Omar contributed to the Bispecific Antibody FS222 team, and as a Research Scientist in Cell and Molecular Biology at Artios, implementing CRISPR/Cas9 technologies. Omar's academic background comprises a PhD in Biomedical Sciences from The University of Edinburgh, along with an ongoing Executive MBA from Hult International Business School, and a Master's and Bachelor's from the same institution and the University of Stirling, respectively. Research expertise includes cancer biology, inflammation, and advanced cellular techniques.
This person is not in any teams
This person is not in any offices
Mestag Therapeutics
Mestag was founded in 2020 by leading investigators and SV Health Investors to develop new medicines for people affected by inflammatory disease and cancer.